Kainate receptor-selective epimeric analogs of dysiherbaine

Details Kainate receptor-selective epimeric analogs of dysiherbaine Kainate receptor-selective epimeric analogs of dysiherbaine

2011-07-05

2011-07-05

Royds Draper, Leslie A (Department: 1614)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C549S396000

Reexamination Certificate

active

07973075

ABSTRACT:
Disclosed are compounds, pharmaceutical compositions, methods of treatment, and methods for selectively antagonizing a GluR5 receptor, a GluR6 receptor, or both receptors. The pharmaceutical compositions include and the methods utilize compounds that are analogs and stereoisomers of dysiherbaine and neodysiherbaine which have specificity for kainate receptors.

REFERENCES:
Greicius et al. “Presenile Dementia Syndrome: An Update on Taxonomy and Diagnosis”. Journal of Neurol. Neurosurg. Psychiatry. 2002; 72:691-700.
Gauthier et al. “Alzheimer's Disease: Current Knowledge, Management and Research”. Can Med Assoc J., 1997; 157(8):1047-1052.
Gasparini et al. “Peripheral Markers in Testing Pathophysiological Hypotheses and Diagnosing Alzheimer's Disease”. FASEB J. 12, 1998:17-34.
“Treatment”. National Institute of Aging [Online]. [Retrieved Dec. 9, 2009]. Retrieved from the Internet: <URL:http://www.nia.nih.gov/Alzheimers/AlzheimersInformation/Treatment>.
“Alzheimer's Disease and Related Dementias.” Cecil's Textbook of Medicine (Twenty-First Edition, vol. 1). W.B. Saunders Company. 2000; pp. 2042-2045.
Vippagunta et al. “Crystalline Solids”. Advanced Drug Delivery Reviews. 2001; 48:3-26.
Shoji et al. “Total Synthesis and Biological Evaluation of Neodysiherbaine A and Analogues”. J. Org. Chem. 71(14); 2006:5208-5220.
Konosu et al. “Beta-Lactam Antifungals.II. Enantiocontrolled Synthesis of (2R,5S)-2-Hydroxymethyl-1-carbapenam, the Carba-Analog of a Clavam Antifungal”. Chem. Pharm. Bull. 39(11); 1991:2813-2818.
Tamura et al., “Stereoselective Syntheses of 4-Hydroxy 4-Substituted Glutamic Acids”, Journal of Organic Chemistry, 2005, 70:4569-4577.
Valgeirsson et al., “2-Arylureidobenzoic Acids: Selective Noncompetitive Antagonists for the Homomeric Kainate Receptor Subtype GluR5”, Journal of Medical Chemistry, 2003, 46:5834-5843.
Valgeirsson et al., “Bioisosteric Modifications of 2-Arylureidobenzoic Acids: Selective Noncompetitive Antagonists for the Homomeric Kainate Receptor Subtype GluR5”, Journal of Medical Chemistry, 2004, 47:6948-6957.
Valluru et al., “Ligand Binding is a Critical Requirement for Plasma Membrane Expression of Heteromeric Kainate Receptors”, Journal of Biological Chemistry, Feb. 18, 2005, pp. 6085-6093, vol. 280, No. 7.
Vivithanaporn et al., “Intracellular Trafficking of KA2 Kainate Receptors Mediated by Interactions with Coatomer Protein Complex I (COPI) and 14-3-3 Chaperone Systems”, Journal of Biological Chemistry, Jun. 2, 2006, pp. 15475-15484, vol. 281, No. 22.
Vivithanaporn et al., “Critical Roles for the M2-S2 Transduction Linker Domain in Kainate Receptor Assembly and Postassembly Trafficking”, Journal of Neuroscience, Sep. 26, 2007, pp. 10423-10433, vol. 27, No. 39.
Weiss et al., “Pharmacological characterization of the Competitive GLU K5 Receptor Antagonist Decahydroisoquinoline LY466195 in Vitro and in Vivo”, Journal of Pharmacology and Experimental Therapeutics, 206, pp. 772-781, vol. 318, No. 2.
Werner et al., “Cloning of a putative high-affinity kainate receptor expressed predominantly in hippocampal CA3 cells”, Nature, Jun. 27, 1991, 351:742-744.
Yan et al., “A C-Terminal Determinant of GluR6 Kainate Receptor Trafficking”, Journal of Neurosciences, Jan. 21, 2004, pp. 679-691, vol. 24, No. 3.
Alt et al., “Anxiolytic-like effects through a GLUK5 kainate receptor mechanism”, Neuropharmacology, 2007, 52:1482-1487.
Ben-Ari et al., “Kainate, a double agent that generates seizures: two decades of progress”, Trends in Neuroscience, 2000, 23(11):580-587.
Brickley et al., “CNQX increases GABA-mediated synaptic transmission in the cerebellum by an AMPA/kainate receptor-independent mechanism”, Neuropharmacology, 2001, 41:730-736.
Bunch et al., “Subtype Selective Kainic Acid Receptor Agonists: Discovery and Approaches to Rational Design”, Medicinal Research Reviews, 2009, pp. 3-28, vol. 29, No. 1.
Chen et al., “Pharmacological insights obtained from structure-function studies of ionotropic glutamate receptors”, British Journal of Pharmacology, 2006, pp. 839-853, vol. 147.
Christensen et al., “In Vitro Characterization of 5-Carboxyl-2, 4-di-benzamido-benzoic Acid (NS3763), a Noncompetitive Antagonist of GLU K5 Receptors”, Journal of Pharmacology and Experimental Therapeutics, 2004, pp. 1003-1010, vol. 309, No. 3.
Cohen et al., “Design, synthesis, and biological evaluation of a scaffold for iGluR ligands based on the structure of (−)-dysiherbaine”, Bioorganic & Medicinal Chemistry Letters, 2006, 16:2189-2194.
Contractor et al., “Identification of the Kainate Receptor Subunits Underlying Modulation of Excitatory Synaptic Transmission in the CA3 Region of the Hippocampus”, Journal of Neuroscience, Nov. 15, 2000, pp. 8269-8278, vol. 20, No. 22.
Contractor et al., “Kainate Receptors Are Involved in Short- and Long-Term Plasticity at Mossy Fiber Synapses in the Hippocampus”, Neuron, Jan. 2001, pp. 209-216, vol. 29.
Contractor et al., “Loss of Kainate Receptor-Mediated Heterosynaptic Facilitation of Mossy-Fiber Synapses in KA2 Mice”, Journal of Neurosciences, Jan. 15, 2003, pp. 422-429, vol. 23, No. 2.
Dolman et al., “Synthesis and Pharmacological Characterization of N3-Substituted Willardiine Derivatives: Role of the Substituent at the 5-Position of the Uracil Ring in the Development of Highly Potent and Selective GLUK5 Kainate Receptor Antagonists”, Journal of Medicinal Chemistry, 2007, 50:1558-1570.
Epsztein et al., “Recurrent Mossy Fibers Establish Aberrant Kainate Receptor-Operated Synapses on Granule Cells from Epileptic Rats”, Journal of Neuroscience, Sep. 7, 2005, pp. 8229-8239, vol. 25, No. 36.
Filla et al., “Ethyl (3S,4a,6S,8aR)-6-(4-Ethoxycarbonylimidazol-1-ylmethyl)decahydroisonquinoline-3-carboxylic Ester: A Prodrug of a GluR5 Kainate Receptor Antagonist Active in Two Animal Models of Acute Migraine”, Journal of Medicinal Chemistry, 2002, 45:4383-4386.
Fisahn et al., “Distinct Roles for the Kainate Receptor Subunits GluR5 and GluR6 in Kainate-Induced Hippocampal Gamma Oscillations”, Journal of Neuroscience, Oct. 27, 2004, pp. 9658-9668, vol. 24, No. 43.
Frisch, “Gaussian 09W Reference”, (2004) Gaussian 03.
Herb et al., “The KA-2 Subunit fo Excitatory Amino Acid Receptors Shows Widespread Expression in Brain and Forms Ion Channels with Distantly Related Subunits”, Neuron, Apr. 1992, 8:775-785.
Hollmann et al., “Cloned Glutamate Receptors”, Annual Review of Neuroscience, 1994, 17:31-108.
Jones et al., “Development and Validation of a Genetic Algorithm for Flexible Docking”, Journal of Molecular Biology, 1997, 267:727-748.
Kew et al., “Ionotropic and metabotropic glutamate receptor structure and pharmacology”, Psychopharmacology, 2005, 179:4-29.
Lash et al., “Novel Analogs and Steroisomers of the Marine Toxin Neodysiherbaine with Specificity for Kainate Receptors”, Journal of Pharmacological and Experimental Therapeutics, Feb. 2008, pp. 484-496, vol. 324, No. 2.
Lerma et al., “Molecular Physiology of Kainate Receptors”, Physiological Reviews, Jul. 2001, 81(3):971-998.
Lerma, “Kainate Receptor Physiology”, Current Opinion in Pharmacology, 2006, 6:89-97.
Mayer, “Crystal Structures of the GluR5 and GluR6 Ligand Binding Cores: Molecular Mechanisms Underlying Kainate Receptor Selectivity”, Neuron, Feb. 17, 2005, pp. 539-552, vol. 45.
Minei, “Effects of a New Excitotoxic Amino Acid, Dysiherbaine, on Cultured Muller Cells”, Japanese Journal of Ophthalmology, 2002, 46:153-159.
Mulle et al., “Altered synaptic physiology and reduced susceptibility to kainate-induced seizures in Gl

Affiliated with

Also associated with

Rating

Kainate receptor-selective epimeric analogs of dysiherbaine does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Kainate receptor-selective epimeric analogs of dysiherbaine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Kainate receptor-selective epimeric analogs of dysiherbaine will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2733633